Symbols / PRFX $2.49 -2.73% PRF Technologies Ltd.
PRFX Chart
About
PRF Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on the reformulation of established therapeutics and provides an extended period of post-surgical pain relief in Israel. It develops PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia, as well as in Phase 3 clinical trial for pain treatment of patients undergoing bunionectomy and pain treatment of hernia repair operations. The company was formerly known as PainReform Ltd. and change its name to PRF Technologies Ltd. in January 2026. The company was incorporated in 2007 and is based in Tel Aviv-Yafo, Israel.
Fundamentals
Scroll to Statements| Market Cap | 2.10M | Enterprise Value | -1.27M | Income | -4.84M | Sales | 17.00K | Book/sh | 10.29 | Cash/sh | 4.90 |
| Dividend Yield | — | Payout | 0.00% | Employees | 6 | IPO | — | P/E | 0.02 | Forward P/E | -0.21 |
| PEG | — | P/S | 123.70 | P/B | 0.24 | P/C | — | EV/EBITDA | 0.29 | EV/Sales | -74.74 |
| Quick Ratio | 1.75 | Current Ratio | 1.78 | Debt/Eq | 0.23 | LT Debt/Eq | — | EPS (ttm) | -7.47 | EPS next Y | -12.06 |
| EPS Growth | — | Revenue Growth | — | Earnings | 2024-08-15 | ROA | -38.75% | ROE | -90.37% | ROIC | — |
| Gross Margin | 0.00% | Oper. Margin | -162.00% | Profit Margin | 0.00% | Shs Outstand | 844.55K | Shs Float | 808.62K | Short Float | 6.92% |
| Short Ratio | 1.94 | Short Interest | — | 52W High | 17.95 | 52W Low | 1.80 | Beta | 0.71 | Avg Volume | 710.50K |
| Volume | 12.09K | Target Price | — | Recom | None | Prev Close | $2.56 | Price | $2.49 | Change | -2.73% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$2.49
Latest analyst target
3. DCF / Fair value
$-42.67
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$2.49
Low
—
High
—
Mean
—
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2024-10-24 | down | Maxim Group | Buy → Hold | — |
| 2024-06-26 | reit | Maxim Group | Buy → Buy | $2 |
- PRFX SEC Filings - PRF Technologies Ltd. 10-K, 10-Q, 8-K Forms - Stock Titan Wed, 01 Apr 2026 02
- Will PRF Technologies (PRFX) Stock Miss Expectations | Price at $2.60, Down 1.89% - Bollinger Bands - UBND thành phố Hải Phòng Mon, 13 Apr 2026 07
- PRF Technologies stock soars after securing SaaS deal for Romanian solar plant - Investing.com Wed, 11 Feb 2026 08
- What's Going On With Pharma Company PRF Technologies On Tuesday? - Sahm Wed, 08 Apr 2026 06
- PRFX Surges 13% on Vanishingly Thin Volume - Bitget hu, 09 Apr 2026 10
- PRF Technologies Announces 1-for-5 Reverse Share Split Effective February 6, 2026 - The Globe and Mail Wed, 04 Feb 2026 08
- Drop-less cataract therapy and solar AI now drive PRF's 2025 pivot - Stock Titan Fri, 27 Mar 2026 07
- From pain drug to AI solar: PRF Technologies pivots into two big markets - Stock Titan hu, 15 Jan 2026 08
- AI solar platform DeepSolar taps Blade Ranger to chase 150MW+ deals - Stock Titan ue, 17 Mar 2026 07
- PRF Technologies (PRFX) cuts share count with 1-for-5 reverse split - Stock Titan ue, 03 Feb 2026 08
- AI system to monitor 71 MW Romanian solar farm in new PRF deal - Stock Titan Wed, 11 Feb 2026 08
- Data audit for Israeli solar farm: EDF taps PRF's DeepSolar - Stock Titan Wed, 18 Feb 2026 08
- New drop-free eye drug implant shows early safety in cataract surgery - Stock Titan Mon, 12 Jan 2026 08
- PainReform (NASDAQ: PRFX) featured; DeepSolar Predict in NVIDIA Connect, pilot progress - Stock Titan Wed, 05 Nov 2025 08
- [6-K] PRF Technologies Ltd. Current Report (Foreign Issuer) | PRFX SEC Filing - Form 6-K - Stock Titan Fri, 27 Mar 2026 07
Insider Transactions
No recent insider transactions.
Financials
Statement View
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
0.02
|
0.00
|
0.00
|
0.00
|
| Operating Revenue |
|
0.02
|
0.00
|
0.00
|
0.00
|
| Cost Of Revenue |
|
0.07
|
0.00
|
0.00
|
—
|
| Reconciled Cost Of Revenue |
|
0.06
|
0.00
|
0.00
|
—
|
| Gross Profit |
|
-0.05
|
0.00
|
0.00
|
—
|
| Operating Expense |
|
5.07
-65.45%
|
14.67
+53.10%
|
9.58
+8.06%
|
8.87
|
| Research And Development |
|
1.14
-90.29%
|
11.71
+93.95%
|
6.04
+36.48%
|
4.42
|
| Selling General And Administration |
|
3.17
+6.94%
|
2.97
-16.37%
|
3.55
-20.19%
|
4.45
|
| Selling And Marketing Expense |
|
0.16
|
0.00
|
0.00
|
—
|
| General And Administrative Expense |
|
3.01
+1.45%
|
2.97
-16.37%
|
3.55
-20.19%
|
4.45
|
| Salaries And Wages |
|
1.12
+7.18%
|
1.04
-35.01%
|
1.61
-14.65%
|
1.88
|
| Other Gand A |
|
1.54
+1.92%
|
1.51
+11.65%
|
1.36
-18.36%
|
1.66
|
| Total Expenses |
|
5.14
-64.98%
|
14.67
+53.10%
|
9.58
+8.06%
|
8.87
|
| Operating Income |
|
-5.12
+65.09%
|
-14.67
-53.10%
|
-9.58
-8.06%
|
-8.87
|
| Total Operating Income As Reported |
|
-5.12
+65.09%
|
-14.67
-53.10%
|
-9.58
-8.06%
|
-8.87
|
| EBITDA |
|
-4.35
+70.33%
|
-14.66
-53.17%
|
-9.57
-8.08%
|
-8.85
|
| Normalized EBITDA |
|
-4.35
+70.36%
|
-14.66
-29.80%
|
-11.30
-28.48%
|
-8.79
|
| Reconciled Depreciation |
|
0.77
+4737.50%
|
0.02
+6.67%
|
0.01
+0.00%
|
0.01
|
| EBIT |
|
-5.12
+65.09%
|
-14.67
-53.10%
|
-9.58
-8.06%
|
-8.87
|
| Total Unusual Items |
|
-0.00
-133.33%
|
0.01
-99.65%
|
1.73
+2932.79%
|
-0.06
|
| Total Unusual Items Excluding Goodwill |
|
-0.00
-133.33%
|
0.01
-99.65%
|
1.73
+2932.79%
|
-0.06
|
| Net Income |
|
-5.02
+65.57%
|
-14.59
-56.12%
|
-9.34
-6.28%
|
-8.79
|
| Pretax Income |
|
-5.01
+65.61%
|
-14.58
-56.17%
|
-9.34
-6.30%
|
-8.78
|
| Net Non Operating Interest Income Expense |
|
0.11
+26.44%
|
0.09
+105.88%
|
-1.48
-1106.80%
|
0.15
|
| Interest Expense Non Operating |
|
—
|
—
|
—
|
0.00
|
| Net Interest Income |
|
0.11
+26.44%
|
0.09
+105.88%
|
-1.48
-1106.80%
|
0.15
|
| Interest Expense |
|
—
|
—
|
—
|
0.00
|
| Interest Income Non Operating |
|
0.12
+18.81%
|
0.10
-75.12%
|
0.41
+153.75%
|
0.16
|
| Interest Income |
|
0.12
+18.81%
|
0.10
-75.12%
|
0.41
+153.75%
|
0.16
|
| Other Income Expense |
|
-0.00
-133.33%
|
0.01
-99.65%
|
1.73
+2932.79%
|
-0.06
|
| Gain On Sale Of Security |
|
-0.00
-133.33%
|
0.01
-99.65%
|
1.73
+2932.79%
|
-0.06
|
| Tax Provision |
|
0.01
+0.00%
|
0.01
+0.00%
|
0.01
-11.11%
|
0.01
|
| Tax Rate For Calcs |
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
|
| Tax Effect Of Unusual Items |
|
-0.00
-133.33%
|
0.00
-99.65%
|
0.40
+2932.79%
|
-0.01
|
| Net Income Including Noncontrolling Interests |
|
-5.02
+65.57%
|
-14.59
-56.12%
|
-9.34
-6.28%
|
-8.79
|
| Net Income From Continuing Operation Net Minority Interest |
|
-5.02
+65.57%
|
-14.59
-56.12%
|
-9.34
-6.28%
|
-8.79
|
| Net Income From Continuing And Discontinued Operation |
|
-5.02
+65.57%
|
-14.59
-56.12%
|
-9.34
-6.28%
|
-8.79
|
| Net Income Continuous Operations |
|
-5.02
+65.57%
|
-14.59
-56.12%
|
-9.34
-6.28%
|
-8.79
|
| Normalized Income |
|
-5.02
+65.60%
|
-14.59
-36.70%
|
-10.67
-22.06%
|
-8.75
|
| Net Income Common Stockholders |
|
-5.02
+65.57%
|
-14.59
-56.12%
|
-9.34
-6.28%
|
-8.79
|
| Diluted EPS |
|
—
|
-105.52
+14.17%
|
-122.94
+61.25%
|
-317.30
|
| Basic EPS |
|
—
|
-105.52
+14.17%
|
-122.94
+61.25%
|
-317.30
|
| Basic Average Shares |
|
—
|
0.14
+81.90%
|
0.08
+174.30%
|
0.03
|
| Diluted Average Shares |
|
—
|
0.14
+81.90%
|
0.08
+174.30%
|
0.03
|
| Diluted NI Availto Com Stockholders |
|
-5.02
+65.57%
|
-14.59
-56.12%
|
-9.34
-6.28%
|
-8.79
|
| Amortization |
|
0.76
|
—
|
—
|
—
|
| Amortization Of Intangibles Income Statement |
|
0.76
|
—
|
—
|
—
|
| Depreciation Amortization Depletion Income Statement |
|
0.76
|
—
|
—
|
—
|
| Depreciation And Amortization In Income Statement |
|
0.76
|
—
|
—
|
—
|
| Insurance And Claims |
|
0.17
-36.12%
|
0.26
-33.25%
|
0.39
-39.66%
|
0.65
|
| Rent And Landing Fees |
|
0.18
+23.29%
|
0.15
-23.56%
|
0.19
-23.29%
|
0.25
|
| Rent Expense Supplemental |
|
0.18
+23.29%
|
0.15
-23.56%
|
0.19
-23.29%
|
0.25
|
| Total Other Finance Cost |
|
0.01
-28.57%
|
0.01
-99.26%
|
1.89
+14407.69%
|
0.01
|
| Line Item | Trend | 2023-12-31 |
|---|---|---|
| Total Assets |
|
9.93
|
| Current Assets |
|
9.80
|
| Cash Cash Equivalents And Short Term Investments |
|
8.03
|
| Cash And Cash Equivalents |
|
8.03
|
| Other Short Term Investments |
|
0.00
|
| Receivables |
|
0.04
|
| Other Receivables |
|
0.04
|
| Prepaid Assets |
|
1.72
|
| Restricted Cash |
|
0.01
|
| Other Current Assets |
|
—
|
| Total Non Current Assets |
|
0.13
|
| Net PPE |
|
0.13
|
| Gross PPE |
|
0.13
|
| Properties |
|
0.00
|
| Buildings And Improvements |
|
0.09
|
| Other Properties |
|
0.04
|
| Goodwill And Other Intangible Assets |
|
—
|
| Goodwill |
|
—
|
| Other Intangible Assets |
|
—
|
| Total Liabilities Net Minority Interest |
|
2.69
|
| Current Liabilities |
|
2.41
|
| Payables And Accrued Expenses |
|
1.89
|
| Payables |
|
0.22
|
| Accounts Payable |
|
0.22
|
| Current Accrued Expenses |
|
1.67
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
0.47
|
| Current Debt And Capital Lease Obligation |
|
0.06
|
| Current Capital Lease Obligation |
|
0.06
|
| Total Non Current Liabilities Net Minority Interest |
|
0.28
|
| Long Term Debt And Capital Lease Obligation |
|
0.03
|
| Long Term Capital Lease Obligation |
|
0.03
|
| Non Current Deferred Liabilities |
|
0.25
|
| Non Current Deferred Taxes Liabilities |
|
0.25
|
| Stockholders Equity |
|
7.24
|
| Common Stock Equity |
|
7.24
|
| Capital Stock |
|
0.00
|
| Common Stock |
|
0.00
|
| Share Issued |
|
0.01
|
| Ordinary Shares Number |
|
0.01
|
| Treasury Shares Number |
|
0.00
|
| Additional Paid In Capital |
|
49.10
|
| Retained Earnings |
|
-41.86
|
| Minority Interest |
|
—
|
| Total Equity Gross Minority Interest |
|
7.24
|
| Total Capitalization |
|
7.24
|
| Working Capital |
|
7.39
|
| Invested Capital |
|
7.24
|
| Total Debt |
|
0.09
|
| Capital Lease Obligations |
|
0.09
|
| Net Tangible Assets |
|
7.24
|
| Tangible Book Value |
|
7.24
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-3.96
+68.66%
|
-12.62
-88.97%
|
-6.68
-3.41%
|
-6.46
|
| Cash Flow From Continuing Operating Activities |
|
-3.96
+68.66%
|
-12.62
-88.97%
|
-6.68
-3.41%
|
-6.46
|
| Net Income From Continuing Operations |
|
-5.02
+65.57%
|
-14.59
-56.12%
|
-9.34
-6.28%
|
-8.79
|
| Depreciation Amortization Depletion |
|
0.77
+4737.50%
|
0.02
+6.67%
|
0.01
+0.00%
|
0.01
|
| Depreciation |
|
0.01
-6.25%
|
0.02
+6.67%
|
0.01
+0.00%
|
0.01
|
| Amortization Cash Flow |
|
0.76
|
—
|
—
|
—
|
| Depreciation And Amortization |
|
0.77
+4737.50%
|
0.02
+6.67%
|
0.01
+0.00%
|
0.01
|
| Amortization Of Intangibles |
|
0.76
|
—
|
—
|
—
|
| Other Non Cash Items |
|
-0.00
+60.00%
|
-0.01
-100.63%
|
1.58
+514.01%
|
0.26
|
| Stock Based Compensation |
|
0.45
+44.19%
|
0.31
-61.44%
|
0.80
-42.12%
|
1.39
|
| Operating Gains Losses |
|
0.00
+133.33%
|
-0.01
+99.56%
|
-1.36
|
—
|
| Gain Loss On Investment Securities |
|
—
|
—
|
-1.36
|
—
|
| Net Foreign Currency Exchange Gain Loss |
|
0.00
+133.33%
|
-0.01
-200.00%
|
-0.00
|
0.00
|
| Change In Working Capital |
|
-0.15
-109.17%
|
1.66
+1.78%
|
1.63
+142.26%
|
0.67
|
| Change In Prepaid Assets |
|
-0.02
-101.37%
|
1.60
+386.36%
|
0.33
-7.30%
|
0.36
|
| Change In Payables And Accrued Expense |
|
-0.13
-350.00%
|
0.05
-95.99%
|
1.30
+310.76%
|
0.32
|
| Change In Accrued Expense |
|
0.11
+570.83%
|
-0.02
-101.87%
|
1.29
+429.22%
|
0.24
|
| Change In Payable |
|
-0.24
-419.74%
|
0.08
+533.33%
|
0.01
-83.56%
|
0.07
|
| Change In Account Payable |
|
-0.24
-419.74%
|
0.08
+533.33%
|
0.01
-83.56%
|
0.07
|
| Change In Other Current Assets |
|
—
|
—
|
—
|
—
|
| Investing Cash Flow |
|
-0.98
-7453.85%
|
-0.01
-100.22%
|
5.99
+199.75%
|
-6.01
|
| Cash Flow From Continuing Investing Activities |
|
-0.98
-7453.85%
|
-0.01
-100.22%
|
5.99
+199.75%
|
-6.01
|
| Net PPE Purchase And Sale |
|
-0.00
+84.62%
|
-0.01
-44.44%
|
-0.01
-50.00%
|
-0.01
|
| Purchase Of PPE |
|
-0.00
+84.62%
|
-0.01
-44.44%
|
-0.01
-50.00%
|
-0.01
|
| Capital Expenditure |
|
-0.00
+84.62%
|
-0.01
-44.44%
|
-0.01
-50.00%
|
-0.01
|
| Net Investment Purchase And Sale |
|
-1.00
|
0.00
-100.00%
|
6.00
+200.00%
|
-6.00
|
| Purchase Of Investment |
|
-1.00
|
0.00
+100.00%
|
-1.00
+83.33%
|
-6.00
|
| Sale Of Investment |
|
—
|
0.00
-100.00%
|
7.00
|
—
|
| Net Business Purchase And Sale |
|
0.02
|
—
|
—
|
—
|
| Financing Cash Flow |
|
3.82
-56.92%
|
8.86
+92.01%
|
4.62
|
0.00
|
| Cash Flow From Continuing Financing Activities |
|
3.82
-56.92%
|
8.86
+92.01%
|
4.62
|
0.00
|
| Net Issuance Payments Of Debt |
|
—
|
—
|
—
|
—
|
| Issuance Of Debt |
|
—
|
—
|
—
|
—
|
| Long Term Debt Issuance |
|
—
|
—
|
—
|
—
|
| Net Long Term Debt Issuance |
|
—
|
—
|
—
|
—
|
| Net Common Stock Issuance |
|
4.01
-25.08%
|
5.35
+214.15%
|
1.70
|
0.00
|
| Proceeds From Stock Option Exercised |
|
0.00
-100.00%
|
4.75
+23.49%
|
3.85
|
0.00
|
| Net Other Financing Charges |
|
-0.19
+84.62%
|
-1.24
-32.51%
|
-0.93
|
—
|
| Changes In Cash |
|
-1.12
+70.33%
|
-3.77
-196.00%
|
3.93
+131.51%
|
-12.46
|
| Effect Of Exchange Rate Changes |
|
-0.00
-133.33%
|
0.01
+200.00%
|
0.00
|
0.00
|
| Beginning Cash Position |
|
4.27
-46.85%
|
8.04
+95.71%
|
4.11
-75.22%
|
16.57
|
| End Cash Position |
|
3.15
-26.25%
|
4.27
-46.85%
|
8.04
+95.71%
|
4.11
|
| Free Cash Flow |
|
-3.96
+68.68%
|
-12.63
-88.91%
|
-6.69
-3.45%
|
-6.46
|
| Common Stock Issuance |
|
4.01
-25.08%
|
5.35
+214.15%
|
1.70
|
0.00
|
| Issuance Of Capital Stock |
|
4.01
-25.08%
|
5.35
+214.15%
|
1.70
|
0.00
|
| Sale Of Business |
|
0.02
|
—
|
—
|
—
|
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|